[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335383-105":59,"doc-detail-335383-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","systematic-modeling-of-risk-associated-copy-number-alterations-in-cancer","Systematic Modeling of Risk-Associated Copy Number Alterations in Cancer","","The determination of cancer prognosis is crucial for patients and clinicians when planning treatment strategies. Transcriptional signatures and biopsy-derived subtypes are widely used for multiple cancer types, but copy number alterations (CNAs) from genomic data remain underutilized despite their complementary molecular information. A systematic framework assesses the prognostic value of CNAs across 37 cancer types, defining deep versus soft informative features and building four single-data models, then integrating them into multidata models to derive clinically relevant risk groups.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/systematic-modeling-of-risk-associated-copy-number-alterations-in-cancer/335383/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/systematic-modeling-of-risk-associated-copy-number-alterations-in-cancer/335383.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is cancer prognosis important in clinical practice?","Question",{"text":112,"@type":113},"Prognostic risk assessment helps optimize treatment decisions and communicates disease severity to patients and their families.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What do the study's deep and soft CNA feature modes represent?",{"text":117,"@type":113},"They reflect two modes of informative features based on how many alleles are gained or lost in CNAs.",{"name":119,"@type":110,"acceptedAnswer":120},"How broadly can CNA-derived models define risk groups across cancer types?",{"text":121,"@type":113},"The study reports clinically relevant CNA-derived risk groups in 33 of 37 analyzed cancer types (90%).","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335383,1792208419,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Article  \nSystematic Modeling of Risk-Associated Copy Number Alterations in Cancer  \nAlejandra Guardado 1,2, Raúl Aguirre-Gamboa 3,4 and Victor Treviño 1,5, *  \nCitation: Guardado, A.; AguirreGamboa, R.; Treviño, V. Systematic Modeling of Risk-Associated Copy Number Alterations in Cancer. Int. J. Mol. Sci. 2024, 25, 10455. [https://](https://)[ ](https://)[doi.org/10.3390/ijms251910455](doi.org/10.3390/ijms251910455)  \nAcademic Editor: Enrico Gaffo  \nReceived: 12 August 2024  \nRevised: 16 September 2024  \nAccepted: 23 September 2024  \nPublished: 27 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Institute for Obesity Research, Tecnologico de Monterrey, Monterrey 64710, Nuevo León, Mexico; [aleguamen_@hotmail.com](aleguamen_@hotmail.com)  \n2 School of Medicine, Tecnologico de Monterrey, Monterrey 64710, Nuevo León, Mexico  \n3 Committee on Immunology, University of Chicago, Chicago, IL 60637, USA; [raul.aguirre.gamboa@gmail.com](raul.aguirre.gamboa@gmail.com)  \n4 Section of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL 60637, USA  \n5 oriGen Project, Tecnologico de Monterrey, Monterrey 64849, Nuevo León, Mexico  \n* [Correspondence: vtrevino@tec.mx](Correspondence: vtrevino@tec.mx)  \nAbstract: The determination of the cancer prognosis is paramount for patients and medical personnel so that they can devise treatment strategies. Transcriptional-based signatures and subtypes derived from cancer biopsy material have been used in clinical practice for several cancer types to aid insetting the patient prognosis and forming treatment strategies. Other genomic features in cancer biopsies, such as copy number alterations (CNAs), have been underused in clinical practice, and yet they represent a complementary source of molecular information that can add detail to the prognosis, which is supported by recent work in breast, ovarian, and lung cancers. Here, through a systematic strategy, we explored the prognostic power of CNAs in 37 cancer types. In this analysis, we defined two modes of informative features, deep and soft, depending on the number of alleles gained or lost. These informative modes were grouped by amplifications or deletions to form four single-data prognostic models. Finally, the single-data models were summed or combined to generate four additional multidata prognostic models. First, we show that the modes of features are cancer-type dependent, where deep alterations generate better models. Nevertheless, some cancers require soft alterations to generate a feasible model due to the lack of significant deep alterations. Then, we show that the models generated by summing coefficients from amplifications and deletions appear tobe more practical for many but not all cancer types. We show that the CNA-derived risk group is independent of other clinical factors. Furthermore, overall, we show that CNA-derived models can define clinically relevant risk groups in 33 of the 37 (90%) cancer types analyzed. Our study highlights the use of CNAs as biomarkers that are potentially clinically relevant to survival in cancer patients.  \nKeywords: survival models; TCGA; cancer prognosis; biomarkers  \n1. Introduction  \nCancer is the second-leading cause of death worldwide [1] . In clinical practice, prognostic risk assessment is important for optimizing treatment and informing patients and families regarding the severity of the disease [2] . The use of genomic-derived molecular biomarkers from cancer biopsies has been supported by several studies using The Cancer Genome Atlas (TCGA) [3] and the International Network of Cancer Genome Projects (ICGC) [4] cohorts. Moreover, transcriptional sig","cbCaim8Jm9eCeiqo","https://ap.wps.com/l/cbCaim8Jm9eCeiqo","pdf",6279953,15,"English","# Introduction\n## Cancer prognosis and molecular biomarkers\n## Copy number alterations and modeling challenges\n## Study motivation and gap in systematic evaluation","[{\"question\":\"Why is cancer prognosis important in clinical practice?\",\"answer\":\"Prognostic risk assessment helps optimize treatment decisions and communicates disease severity to patients and their families.\"},{\"question\":\"What do the study's deep and soft CNA feature modes represent?\",\"answer\":\"They reflect two modes of informative features based on how many alleles are gained or lost in CNAs.\"},{\"question\":\"How broadly can CNA-derived models define risk groups across cancer types?\",\"answer\":\"The study reports clinically relevant CNA-derived risk groups in 33 of 37 analyzed cancer types (90%).\"}]","Systematic Modeling of Risk-Associated Copy Number Alterations in Cancer | PDF",1790010778,38]